Erectile Dysfunction Treatment
PDE5 inhibitors (selective phosphodiesterase type 5) are the first line of treatment for erectile dysfunction. These drugs are extremely effective, well tolerated, and have excellent safety profiles.
Sildenafil (kamagra oral jelly), vardenafil (Levitra), tadalafil (Cialis), and avanafil (Stendra) are the four phosphodiesterase type 5 inhibitors currently on the market. These drugs affect the response to sexual stimulation rather than directly causing penile erections. The first of these phosphodiesterase type 5 inhibitors was sildenafil.
The choice between a short-acting phosphodiesterase type 5 inhibitor and a long-acting phosphodiesterase type 5 inhibitor is based on the frequency of intercourse (occasional use or regular therapy, 3-4 times weekly), as well as the patient’s personal experience, according to European guidelines.
Alprostadil self-injection, Alprostadil urethral suppository, and Testosterone replacement are some other erectile dysfunction medications.